1218.5.11016 Boehringer Ingelheim Investigational Site

Calgary, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients — Completed